A Jatoi Selected Research

ErbB Receptors (EGF Receptor)

1/2016

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Jatoi Research Topics

Disease

14	Neoplasms (Cancer) 08/2017 - 02/2000
3	Anorexia 08/2017 - 04/2001
3	Weight Loss (Weight Reduction) 08/2017 - 01/2001
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 08/2001
3	Esophageal Neoplasms (Esophageal Cancer) 01/2007 - 01/2006
2	Fatigue 01/2015 - 02/2013
2	Pain (Aches) 01/2015 - 01/2011
2	Adenocarcinoma 04/2006 - 01/2006
2	Lung Neoplasms (Lung Cancer) 02/2004 - 08/2001
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Leukemia 01/2017
1	Mucositis 01/2016
1	Diarrhea 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 01/2015
1	Cachexia 08/2014
1	Inflammation (Inflammations) 08/2014
1	Malnutrition (Nutritional Deficiencies) 08/2014
1	Rectal Neoplasms (Rectal Cancer) 05/2014
1	Infections 01/2006
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2006
1	Respiratory Insufficiency (Respiratory Failure) 01/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Myocardial Infarction 01/2006
1	Deglutition Disorders (Dysphagia) 01/2004
1	Starvation 04/2001
1	Weight Gain 01/2001
1	Male Breast Neoplasms (Male Breast Cancer) 05/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 08/2014 - 05/2000
2	Capecitabine (Xeloda)FDA Link 04/2006 - 01/2006
2	LeptinIBA 01/2004 - 08/2001
2	Neuropeptide YIBA 01/2004 - 08/2001
2	Adenosine Triphosphate (ATP)IBA 04/2001 - 02/2000
1	CreatineIBA 08/2017
1	Amino Acids FDA Link 08/2017
1	AnthracyclinesIBA 01/2017
1	dacomitinibIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011
1	Delayed-Action PreparationsIBA 01/2011
1	Cetuximab (Erbitux)FDA Link 10/2010
1	Docetaxel (Taxotere)FDA Link 04/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2006
1	SmokeIBA 02/2004
1	EnzymesIBA 08/2001
1	Potassium-40IBA 08/2001
1	Appetite Depressants (Anorectics)IBA 08/2001
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2001
1	cholecystokinin 8IBA 08/2001
1	Thalidomide (Thalomid)FDA Link 04/2001
1	Eicosapentaenoic AcidIBA 04/2001
1	Progestins (Progestagens)IBA 04/2001
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2001
1	UbiquitinIBA 01/2001
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2001
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2001
1	Estrogens (Estrogen)FDA Link 05/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2015 - 01/2004
4	Therapeutics 08/2014 - 01/2006
2	Adjuvant Chemotherapy 01/2017 - 05/2014
1	Nutritional Support (Artificial Feeding) 08/2014
1	Ostomy 05/2014
1	Palliative Care (Palliative Therapy) 01/2011
1	Radiotherapy 01/2007
1	Drug Tapering 01/2006